Preclinical Development Plan definition

Preclinical Development Plan means a Development Plan directly relating to a Preclinical Study.
Preclinical Development Plan means, for each Program, the comprehensive plan, overall strategy and timelines, and any updates thereto, for the Preclinical Development of Products directed to the applicable Target for such Program, including a description of the Preclinical Development activities, expected timelines, the preclinical, clinical, manufacturing, regulatory, as well as product risk assessment planned activities up to the issuance of the Final Report by Kite to Amgen. The Preclinical Development Plan shall include, but not be limited to, a reasonably detailed description of the schedule of work activity, the responsibility for the work activities and an associated budget. As the circumstances may require, the JSC may propose from time to time amendments to the Preclinical Development Plan in accordance with Section 2.1.3(b) (Function and Powers of the JSC).
Preclinical Development Plan means, the comprehensive plan, overall strategy and timelines, and any updates thereto, for the Preclinical Development of Products directed against the applicable Collaboration Target for a Program, including a description of the Preclinical Development activities; expected timelines; preclinical, manufacturing, regulatory, as well as product risk assessment planned activities; the Format for such Products; and issuance of the Final Report by CytomX to Amgen. The Preclinical Development Plan shall include, but not be limited to, a reasonably detailed description of the schedule of work activity and the responsibility therefor. As the circumstances may require, the JSC may propose from time to time amendments to the Preclinical Development Plan. For each Collaboration Target, the initial Preclinical Development Plan is as set forth on Exhibit C-2.

Examples of Preclinical Development Plan in a sentence

  • For clarity, after completion of the Preclinical Development Plan, Amgen shall continue to have the right to conduct preclinical development with respect to all Amgen Products.

  • The Parties shall prepare any such Preclinical Development Plan by modeling it after the Standard Preclinical Development.

  • Initiate Preclinical Development Plan for a Licensed Product within three (3) months of the effective date of this Agreement.

  • On a Target-by-Target basis (including for any Additional Targets), upon approval by the JSC of the applicable Preclinical Development Plan, Amgen shall be responsible for the first […***…] of costs and expenses for Preclinical Development of the Parties under each such plan.

  • Following the Effective Date and at all times during the Term (except with respect to Preclinical Development and clinical activities conducted by each Party pursuant to the Preclinical Development Plan and EGFR Initial Development Plan, and except as set forth in clauses (a) and (b) below), Amgen shall be responsible for, and shall bear all costs associated with, the development, manufacture and commercialization of EGFR Products, including development, distribution, marketing and sales activities.

  • The Parties shall promptly generate a Preclinical Development Plan for the Program for such Additional Target in accordance with Section 3.4 (Preclinical Development Plan).

  • Upon approval by the JSC of the applicable Preclinical Development Plan and associated Budget, each Party shall commence and conduct Preclinical Development activities assigned to it under, and in accordance with, such Preclinical Development Plan.

  • Except to the extent included in a Preclinical Development Plan funded pursuant to Section 8.1.3 (Preclinical Development Costs), Kite shall be solely responsible for, and shall bear all costs associated with, the manufacture of Kite Products.

  • During the applicable Preclinical Development Term, each Party shall use its reasonable efforts to conduct its Preclinical Development activities of the corresponding Product in accordance with the corresponding Preclinical Development Plan.

  • The JSC shall promptly direct the Parties to generate a Preclinical Development Plan with respect to each Program (including the assignment of activities between the Parties), as well as the corresponding Budget.


More Definitions of Preclinical Development Plan

Preclinical Development Plan has the meaning set forth in Section 4.01 (Joint Development in the Field in the Territory) hereof.
Preclinical Development Plan means a plan for Preclinical Development of one or more Preclinical Candidates as approved by the Research Committee and the Steering Committee for a Collaboration Project. The Preclinical Development Plan will include a detailed description of the specific responsibilities of each party for various Preclinical Development activities and a proposed timetable for accomplishment of certain objectives for the Collaboration Project.